David Epstein, Ottimo Pharma CEO
David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field
David Epstein has retired three times.
And he quickly went to work when he got back in the saddle earlier this fall as CEO and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
